← Top stories
Policy● Neutral for Indian equities
Mint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registry
The brief
- NHRC wants the drugs regulator to build a national digital registry using QR codes and drug-tracking tools
- A stronger drug-tracking system could affect Indian pharmaceutical companies and healthcare enforcement
- Buy Aster DM Healthcare; target of Rs 910: Motilal Oswal
- Lupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL
- Dr Reddy's shares gain over 1% after Nomura retains 'Buy'; Rs1,740 target, key biologics milestones ahead
- Shrikant Chouhan recommends buying Torrent Pharma, selling Bharti Airtel
- Morepen Laboratories submits first ANDA to USFDA for Sitagliptin Tablets
Digital tools for drug verification and quality reports
An explainer said the NHRC wants India's drugs regulator to create a national digital registry using unique QR codes and tracking tools to verify medicines and trace their movement. The regulator is also developing a digital platform for consumers to view batch-level quality-test reports.
Friday, 25 September
Thursday, 24 September
- Mint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registry